Journal Detail
| Journal Name | |
| ISSN (P) | 2836-2322 |
| ISSN (O) | 2836-2322 |
| Country | United States of America |
| Frequency | Quarterly |
| Journal Discipline | |
| Area of specialization | |
| Organization | |
| Journal Language | |
| Year of First Publication | 2022 |
| Web Site | www.mediresonline.org |
| Editor | Alireza Heidari |
| Indexed | |
| info@mediresonline.org | |
| Phone No. | +17864906788 |
| Cosmos Impact Factor | |
| Journal Description | Pharmacy and Drug Development (ISSN: 2836-2322) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines. Pharmacy and Drug Development (ISSN: 2836-2322) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines. Pharmacy and Drug Development (ISSN: 2836-2322) is an Open Access single blinded peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others. Pharmacy and Drug Development (ISSN: 2836-2322) focuses on drug-related disorders, pharmacological complications, therapeutic innovations, formulation challenges, and clinical applications of new medicines. The current research in Pharmacy and Drug Development (ISSN: 2836-2322) involves the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners, and even common people. |


